[Proignostic Factors of Cardiovascular Complications After Ischemic Stroke]

Kardiologiia
|April 30, 2016
PubMed

Insights

Predictors of cardiovascular events after ischemic stroke include older age, heart disease, arrhythmias, and low SDNN. Absence of thiazide diuretics was also a risk factor. This research identifies key indicators for patient risk stratification.

Area of Science:

  • Neurology
  • Cardiology
  • Epidemiology

Background:

  • Ischemic stroke survivors face a high risk of subsequent cardiovascular events (CVE).
  • Identifying predictors of CVE is crucial for secondary prevention strategies.
  • Previous studies have explored various risk factors, but comprehensive analysis in this cohort is needed.

Purpose of the Study:

  • To identify independent predictors of cardiovascular events (CVE) in patients following an ischemic stroke.
  • To analyze the association between baseline characteristics, comorbidities, and antihypertensive therapy with CVE occurrence.
  • To inform secondary prevention guidelines for ischemic stroke patients.

Main Methods:

  • Prospective cohort observational study including 148 ischemic stroke patients (aged 60 [52; 68] years).
  • Follow-up duration of 35 [28; 40] months, registering recurrent stroke, transient ischemic attack, myocardial infarction, unstable angina, heart failure, and cardiovascular death.
  • Multivariate regression analysis was employed to determine independent predictors of CVE.

Main Results:

  • During follow-up, 37 patients (25%) experienced 50 CVE.
  • Independent predictors of CVE included age over 67 years, chronic ischemic heart disease, and high-grade ventricular arrhythmias.
  • Low standard deviation of cardiointervals (SDNN) (< 71 ms) and absence of thiazide diuretics in antihypertensive therapy were also significant predictors.

Conclusions:

  • Age, chronic ischemic heart disease, ventricular arrhythmias, low SDNN, and lack of thiazide diuretic use are significant independent predictors of CVE after ischemic stroke.
  • These findings highlight the importance of comprehensive risk assessment and tailored antihypertensive strategies in stroke survivors.
  • Further research should focus on the mechanisms underlying these associations and the efficacy of interventions targeting these predictors.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
5.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K